Overview: Recent research has revealed the profound impact of psychedelics on the brain, sparking interest in their therapeutic potential. This blog explores three prominent theories — Cortico-Striato-Thalamo-Cortical (CSTC), Relaxed Beliefs Under Psychedelics (REBUS), and Claustro-Cortical Circuit (CCC) — that shed light on how psychedelics alter brain function:
Despite differences in these theories, they all provide valuable insights into the neural mechanisms underlying the effects of psychedelics. Continued research in this field promises to deepen our understanding of these fascinating substances and their therapeutic potential.
In recent years, research has unveiled the profound impact that psychedelics can have on the brain. From altering perception to potentially treating mental health disorders, these substances have captivated scientists and enthusiasts alike.
A 2022 paper outlined proposed possible mechanisms that may underlie the effects and therapeutic potential of psychedelics. Through experimentation and analysis, researchers have begun to unravel how psychedelics influence neural processes, shedding light on their psychedelic effects and therapeutic applications.
In the scientific literature, several neuroscientific explanations have been proposed to account for the effects of psychedelics at a neural-level. These include how psychedelics weaken the brain’s natural filters, disrupt the brain’s normal prediction process and heighten sensitivity to unexpected signals, and activate a specific brain circuit called the claustro-cortical circuit.
This blog provides a brief overview of three of the most prominent explanations: the Thalamo-Cortical Filter Theory, the Relaxed Beliefs Under Psychedelics (REBUS) Model, and the Claustro-Cortical Circuit (CCC) Model. By exploring these theories, this blog aims to shed light on the neural mechanisms underlying the therapeutic potential of psychedelics.
One of the earliest and most influential theories regarding the effects of psychedelics on the brain is the Cortico-Striato-Thalamo-Cortical (CSTC) theory. This theory helps explain how these substances might alter our perception (how we perceive ourselves and theworld round us), cognition (thinking and mental processes e.g. attention, memory, reasoning), and emotion (feelings and mood) by influencing the brain’s sensory filters.
The CSTC model suggests that psychedelic work by disrupting the normal feedback loops between the cortex (the brain's outer layer responsible for higher-order functions) and the thalamus (a relay station for sensory and motor signals). These loops usually help prevent sensory overload by filtering incoming information.
Key Components:
Under normal conditions, the thalamus acts like a gatekeeper, controlling the flow of sensory and internal (interoceptive) signals to the cortex. The prefrontal cortex (PFC) regulates this filtering process, ensuring that we’re not overwhelmed by too much information.
When psychedelics are introduced, this gating mechanism is disrupted. Here's how:
Early PET (Positron Emission Tomography) studies and more recent fMRI (Functional Magnetic Resonance Imaging) studies have shown that psychedelics alter the activity and connectivity between the PFC and the thalamus. These changes in brain activity correlate with the subjective experiences reported by participants, such as intensified sensory perception.
For instance, enhanced connectivity between the thalamus and other brain regions has been observed with LSD use. However, increased thalamic activity during acute psychedelic effects is not always consistently observed.
Despite its insights, the CSTC model has limitations. Behavioral studies that measure reduced thalamic gating show mixed results when participants are under the influence of psychedelics. Thus, while the CSTC model explains some neural and experiential changes caused by psychedelics, it doesn’t capture the full complexity of their effects.
The CSTC theory provides a valuable framework for understanding how psychedelics might intensify sensory processing and alter our perceptions. By disrupting the normal filtering mechanisms in the brain, these substances can lead to a flood of sensory and internal information, contributing to the profound experiences associated with their use. While the model has its limitations, it remains a crucial piece in the puzzle of understanding psychedelics' impact on the brain.
The REBUS (Relaxed Beliefs Under Psychedelics) model offers an integrative framework for understanding the effects of psychedelics on the brain. This model combines the “entropic brain hypothesis” with the “free-energy principle” to explain how psychedelics might alter our perception, cognition, emotion, and therapeutic potential.
Under normal circumstances, our brain functions like a prediction machine. It constantly generates predictions to explain away incoming sensory information, creating a coherent experience of the world. This process involves a hierarchical model where the brain makes predictions and compares them to actual sensory input. When there is a mismatch, a prediction error signal is generated, prompting the brain to update its model to better match reality.
Prediction-error signaling is fine-tuned by precision-weighting, where more reliable sensory signals are given higher confidence for belief updating.
Classic psychedelics, such as LSD and psilocybin, act primarily on 5-HT2A receptors. This action leads to excessive excitability of deep-layer pyramidal neurons, which are crucial for encoding the precision of beliefs. As a result, prediction errors are less suppressed, and the brain becomes more sensitive to new sensory information.
According to the REBUS model, psychedelics loosen rigid prior predictions and increase sensitivity to bottom-up sensory information. This mechanism can help to explain various psychedelic experiences:
These visual effects are typically strongest with closed eyes, where there is no external input to correct the brain’s internal models.
At higher doses, psychedelics affect more high-level brain regions, altering perceptions of the self and high-level beliefs. The Default Mode Network (DMN), which is involved in mind-wandering and self-referential thinking, is a key area impacted by psychedelics.
fMRI studies show that during a psychedelic experience, DMN activity decreases, correlating with experiences of ego-dissolution. This suggests that psychedelics can loosen high-level beliefs and schemas related to the self.
Interestingly, some studies show increased prefrontal activity during psychedelic experiences, highlighting potential methodological differences or the dynamic nature of these experiences.
The REBUS model also draws from the entropic brain hypothesis, which posits that psychedelics increase brain entropy—creating a more disordered and interconnected state compared to normal waking consciousness.
The entropic state might explain the unpredictable nature of psychedelic experiences, similar to the analogy of wiping out beaten tracks on a skiing hill, forcing one to explore new paths.
The REBUS model offers insights into the therapeutic effects of psychedelics. Disorders like depression and OCD are often characterized by rigid, maladaptive beliefs. Psychedelics can temporarily loosen these beliefs, making individuals more open to new perspectives.
While the REBUS model is influential, it faces conceptual and methodological criticisms. For instance, psychedelics could potentially strengthen some beliefs, and small sample sizes in fMRI studies limit generalizability. Additionally, other substances like SSRIs also alter DMN connectivity, suggesting that some effects might not be unique to psychedelics.
Moreover, psychedelics significantly impact other brain networks, such as the task-positive network and the salience network, indicating a broader range of effects.
The REBUS model provides a compelling framework for understanding how psychedelics can disrupt rigid beliefs and promote new perspectives. By increasing brain entropy and altering connectivity, psychedelics can lead to profound changes in perception, cognition, and emotion, offering potential therapeutic benefits for various mental health conditions. While the model has its limitations, it remains a vital piece in the ongoing exploration of psychedelic science.
The Claustro-Cortical Circuit (CCC) model offers another perspective on how psychedelics affect the brain, particularly focusing on the role of the claustrum—a small, mysterious structure nestled deep within the brain.
The claustrum is a small, thin structure located beneath the cerebral cortex. Despite its size, it boasts a high density of 5-HT2A receptors — the same receptors targeted by classic psychedelics. The claustrum is intricately connected to various brain regions, making it a key player in coordinating neural activity.
According to the CCC model, the claustrum supports cortical network states, acting as a sort of conductor for brain activity. When the claustrum is directly activated, it triggers widespread cortical activation, influencing various cognitive processes.
Psychedelics, by activating 5-HT2A receptors in the claustrum, may destabilize these canonical brain network states. This destabilization can lead to a decoupling between prefrontal areas and the claustrum, disrupting coordination and reducing cognitive control.
Support for the CCC model comes from studies showing that psilocybin decreases claustrum activity, which correlates with the experience of ineffability—the feeling of being unable to fully describe or articulate one’s psychedelic experiences in words.
While the CCC model offers valuable insights, it also faces limitations. For instance, it's unclear exactly how psychedelics affect specific brain circuits through changes in the claustrum. Additionally, the highly variable effects of psychedelics suggest that generalized brain network instability may not fully explain all subjective experiences.
While psychedelic experiences can indeed vary widely from person to person and even within the same individual across different sessions, there are certain effects that seem to reliably occur, as evidenced by several reports from study participants displaying orderly dose effects.
Despite this variability, it's unclear how reduced cognitive control alone could account for convergences on some self-reported acute subjective effects. This raises questions about the mechanisms underlying these shared experiences and suggests that additional factors may be at play.
Despite these challenges, the CCC model synthesizes scientific observations and highlights the role of the claustrum in coordinating brain activity. While it may not provide a complete explanation for all effects of psychedelics, it contributes to our understanding of how these substances impact the brain.
The CCC model sheds light on the interplay between psychedelics and the claustrum — a crucial hub for coordinating brain activity. By disrupting canonical brain network states, psychedelics challenge traditional notions of cognitive control and perception.
While the CCC model faces challenges in fully explaining the diverse effects of psychedelics, it represents a significant step forward in unraveling the mysteries of these fascinating substances. Continued research into the role of the claustrum and its interactions with psychedelics promises to deepen our understanding of consciousness and cognition.
In conclusion, the exploration of neural mechanisms underlying the effects of psychedelics offers a fascinating glimpse into the complex interplay between these substances and the brain. While each theory — CSTC, REBUS, and CCC — provides valuable insights, none may fully capture the entirety of psychedelic experiences, yet at least.
Yet, collectively, they contribute to our understanding of how psychedelics alter perception, cognition, emotions, and consciousness. As research in this field continues to evolve, we can anticipate further revelations that may unlock new therapeutic potentials and deepen our appreciation of the profound effects of psychedelics on the human mind.
The Physician
Contact :
jamesabad28@gmail.comTest Answer 222
JABAD1999
Contact :
hello@dranaholmes.comTest Answer
Dr. Ana Holmes, Physican, Philadelphia, US
Contact :
bailey@blackpeak.caTest Answer 2
Bailey
Content from the community
Contact :
bailey@blackpeak.caTest Answer 3
Bailey
Contact :
bailey@blackpeak.caTest Answer 2
Bailey
The Scientist
Contact :
hello@dranaholmes.comTest Answer
Dr. Ana Holmes, Physican, Philadelphia, US